Absolutely agree!

Great to see Simoa blood based biomarkers tracking with amyloid PET and the significant impact on plaque reduction of Donanemab! #AAIC21

Excited to announce the appointment of six new individuals to our Scientific Advisory Board! Please join us in welcoming Ileana Cristea, jennifer van eyk, Anne-Claude Gingras, Jesper Olsen, Renã AS Robinson, and @JohnRYatesIII. Read more details here: 908devices.com/news/908-devic…

Please join me now on MultipleSclerosis_CME for my accredited tweetorial launching TODAY on MRI and #biomarkers in the diagnosis of #multiplesclerosis. Free CE/#CME!! Follow us, Samuel F. Hunter Jacqueline Nicholas MD MPH Aaron Boster MD Dr. Brandon Beaber @EmilyPharrMD Dr Niall MacDougall Stacey Clardy MD PhD

Outstanding work shown at #AACI21. The Quanterix team will remain focused on bringing key #biomarkers to these researchers as we pioneer a new field of ‘neuro diagnostic therapies’ to improve outcomes for those suffering from diseases like #Alzheimers! bit.ly/2VDD9AE

Love this countdown and this research! What was your favorite abstract or preso from #AAIC21 ?

Interesting food for thought for those of us in #healthcare. MLB veteran Theo Epstein at #HIMSS21 drew a parallel between baseball and analytics, teamwork and culture. Awesome read! bit.ly/3jITw7x

👏👏

I’ll be chatting with Nicholas Ashton on his work with some special biomarkers!

Join Kevin Hrusovsky on September 16th as he discusses how Emory University implemented COVID-19 testing for their students, faculty, and staff with Dr. John D. Roback, Professor in the Department of Pathology and Laboratory Medicine. Register: bit.ly/3E4YdC0

The U.S. FDA's Breakthrough Device designation for the Simoa pTau-181 #bloodtest marks yet another important milestone in our Powering #PrecisionHealth journey. As an aid in diagnosing #Alzheimers, we're closer to our goal of using #biomarkers to #EndAlz! bit.ly/30tb01R

Congratulations, Luba Greenwood. This is terrific news and huge for women in #biotech – a woman CEO with an all-woman C-suite!

A new #cancer drug gets #FDA ✅: Patients with early-stage HR+ and HER2- early #breastcancer could have a new standard of care, with #Verzenio now approved. An incredible advancement that will help countless patients in their fight. wb.md/3nhFOdQ

Congratulations to David Walt on being awarded the prestigious Northwestern Kabiller Prize! David is a #precisionhealth pioneer whose contributions to modern medicine – including Simoa – have revolutionized how we detect and treat #cancer and disease! bit.ly/3wfoIRV

Through Quanterix and PoweringPrecisionHealth, the goal is to revolutionize the way #healthcare is provided, from reactive sick care to truly preventative healthcare. Had a great opportunity to share this vision with The Boston Globe: bit.ly/3Fh1xtR #precisionhealth

Had a great time presenting on Quanterix’s 2021 achievements at the J.P. Morgan Healthcare Conference this morning! Exciting developments ahead: bwnews.pr/3rdC6nd #JPM22

As always, great conversation with Bloomberg Bay Biz this week on Quanterix’ 2021 milestones! Thanks for the opportunity, @AnneMostue.

#ICYMI: At #JPM22 yesterday, we discussed how Quanterix is disrupting #proteomics, particularly in #neuro and #Alzheimers research. Excited to see the breakthroughs discovered and advances in diagnostics made through the support of #Simoa and PoweringPrecisionHealth! bit.ly/3fnpQv9

A new Science Magazine study has revealed the critical role NfL plays in #MS research! Thanks to Quanterix’s ability to measure NfL at ultra-low levels, researchers found that Epstein-Barr virus greatly increased the risk of subsequent MS: bit.ly/33QG4dx

Thrilled to announce that Quanterix is partnering with and received funding from Alzheimer's Drug Discovery Foundation to accelerate the development of a #multianalyte plasma test for #Alzheimers. Learn more about the advancements we hope to spearhead with ADDF & @AmsterdamUMC: bwnews.pr/3LqZlmg